Open Access6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.
Author(s) -
Robertson Pratt,
Muriel Loosemore
Publication year - 1978
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.75.9.4145
Subject(s) - chemistry , beta lactamase inhibitors , beta (programming language) , enzyme , escherichia coli , benzylpenicillin , penicillin , epimer , bacillus cereus , bacillus licheniformis , substrate (aquarium) , biochemistry , cereus , stereochemistry , bacteria , biology , antibiotics , gene , ecology , genetics , bacillus subtilis , computer science , programming language
6-beta-Bromopenicillanic acid, which arises from the epimerization of 6-alpha-bromopenicillanic acid in aqueous solution or from hydrogenation of 6,6-dibromopenicillanic acid, is a powerful, irreversible, active-site-directed inhibitor of several typical beta-lactamases (penicillinase; penicillin amido-beta-lactamhydrolase, EC 3.5.2.6); 6-alpha-bromopenicillanic acid, being completely inhibited at less than micromolar concentrations through what is probably a 1:1 interaction. The B. licheniformis exoenzyme is similarly susceptible, while the Staphylococcus aureus enzyme and the Escherichia coli (R factor) enzyme are less so; the B. cereus beta-lactamase II is not inhibited. Very high concentrations (greater than or equal to 0.1 M) of benzylpenicillin, a good substrate, are required to significantly reduce the rate of inhibition of B. cereus beta-lactamase I by 6-beta-bromopenicillanic acid.